The new 176,000sq ft site will support future growth for Meissner Filtration Products, whose range of products include a number of microfiltration systems used for downstream processes in biomanufacturing.
“Meissner needed to expand its operational footprint to include a facility that would accommodate growth both in terms of production capacity as well as support services,” the firm’s Director of Operations, Max Blomberg, told Biopharma-Reporter.com.
He added the site in Camarillo, California “facilitates both of these goals via 40,000 sq ft of cleanroom manufacturing space, as well as state of the art laboratory facilities with support functions including testing, advanced analytics, validation services, and product development.”
The expansion is part of Meissner’s vertical integration strategy which Blomberg told us has enabled the firm “to design products to be as pure as possible, at a time when the benefits of such efforts were largely theoretical, but now have demonstrated tangible benefits.”
Meissner offers a number of disposable biocontainers, rigid outer containers and fluid path assemblies under its One-Touch portfolio, in order to support the adoption of single-use In bioprocessing.
“Any time a new technology is introduced, adoption is best undertaken to minimize risk and maximize reward,” Blomberg said. “We do not think anything is holding back single-use filtration products or systems at large.”
However, he continued, each application should undergo its own risk analysis to ensure the desired benefits are achieved and “in many cases, the optimum solutions remain hybrid systems where traditional multi-use systems are integrated with single-use technology to maximize the benefits of both.”